Mortality in Switzerland in 2021.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2022
2022
Historique:
received:
08
04
2022
accepted:
26
08
2022
entrez:
9
9
2022
pubmed:
10
9
2022
medline:
14
9
2022
Statut:
epublish
Résumé
To analyze mortality trends in Switzerland in 2021, the second year of the COVID-19 pandemic. Using data from the Swiss Federal Statistical Office, we compared mortality in Switzerland in 2021 with that of previous years in terms of standardized weekly deaths, standardized (annual) mortality rates (overall and stratified by age and sex) and life expectancy. The latter is a well-known demographic concept defining the average lifespan of a hypothetical cohort living and dying according to the mortality rates of a given year. After a favorable first half of the year and a fairly standard second half in terms of mortality in Switzerland, the year 2021 ended with a wave of deaths of moderate intensity related to the 5th wave of COVID-19. Overall, and after a notable increase in mortality in 2020 (+9.2%, 95%CI: +8.0%; +10.3%, compared to 2019, and +5.1%, 95%CI: +4.3%; +6.0%, compared to 2015-19), the pre-pandemic mortality level was approximately recovered in 2021 (+0.8%, 95%CI: -0.3%; +0.8%, compared to 2019, and -2.9%, 95%CI: -3.7%; -2.2%, compared to 2015-19). Life expectancy, after declining by 10 months for men and 6 months for women in 2020 (i.e. men would have lost 10 months and women 6 months had they lived their entire lives with COVID-19 as it was in 2020), returned in 2021 to 2019 levels for women (85.6 years) and regained 2018 levels for men (81.6 years, still -0.3 years from 2019). The age group responsible for the small remaining loss for men was the 50-70 age group, which had similar mortality in 2020 and 2021. The second year of the COVID-19 pandemic in Switzerland was characterized by an approximate return to pre-pandemic mortality levels, with a faster recovery for women than for men with respect to 2020.
Identifiants
pubmed: 36084010
doi: 10.1371/journal.pone.0274295
pii: PONE-D-22-10389
pmc: PMC9462753
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0274295Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
JAMA. 2021 Apr 2;:
pubmed: 33797550
J Epidemiol Community Health. 2021 Aug;75(8):735-740
pubmed: 33468602
Proc Natl Acad Sci U S A. 2020 Sep 8;117(36):22035-22041
pubmed: 32820077
BMJ Open. 2021 Mar 10;11(3):e042934
pubmed: 33692179
J R Soc Med. 2020 Sep;113(9):329-334
pubmed: 32910871
Influenza Other Respir Viruses. 2009 May;3(3):99-106
pubmed: 19453486
BMJ. 2021 May 19;373:n1137
pubmed: 34011491
Elife. 2021 Jun 30;10:
pubmed: 34190045
Lancet. 2022 Apr 16;399(10334):1513-1536
pubmed: 35279232
PLoS One. 2021 Jun 17;16(6):e0253505
pubmed: 34138948
Healthy People 2000 Stat Notes. 1995 Mar;(6):1-10
pubmed: 11762384
Proc Natl Acad Sci U S A. 2021 Feb 2;118(5):
pubmed: 33446511
Int J Epidemiol. 2022 Feb 18;51(1):63-74
pubmed: 34564730
Ann Intern Med. 2022 Apr;175(4):523-532
pubmed: 35099995
Int J Epidemiol. 2015 Oct;44(5):1549-56
pubmed: 26108436
MMWR Morb Mortal Wkly Rep. 2021 Apr 09;70(14):519-522
pubmed: 33830988